Correction to: International Journal of Hematology https://doi.org/10.1007/s12185-018-2499-y
The authors would like to correct the errors in the publication of the original article. The correction details are given below:
The first sentence under the subheading “Impact of demographic factors on the development of FVIII inhibitors” on page 7 should read as “The risk assessment revealed that a known family history of inhibitor formation against FVIII was significantly associated with known development of FVIII inhibitor (Fisher’s exact test: P valuetwo−sided= 0.0004).”
The third sentence under the “Acknowledgements” section should read as “Dr. Hanabusa was instrumental in gaining approval for this product in Japan, and the creation and interpretation of the data included herein, and would have been a co-author of this manuscript.”
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Taki, M., Fukutake, K., Matsushita, T. et al. Correction to: Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan. Int J Hematol 109, 241 (2019). https://doi.org/10.1007/s12185-018-02564-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-018-02564-z